Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Relationship Between Inflammatory Markers, Angiogenesis, and Obesity



Tahergorabi Z1, 2 ; Khazaei M1, 2
Authors

Source: ARYA Atherosclerosis Published:2013

Abstract

Obesity is recognized as a chronic low grade and systemic inflammatory disease. Angiogenesis is critical for adipose tissue expansion. Several evidences have demonstrated that angiogenesis sustains inflammation by preparing oxygen and nutrients for inflammatory cells and inflammation in turn can cause insulin resistance, type 2 diabetes, and cardiovascular disease. The understanding of mechanisms of obesity especially main roles of inflammation and angiogenesis in fat mass expansion can lead to therapeutic approaches in growing field of obesity and its related disorders. In this review, we studied the relationship between obesity, angiogenesis, and inflammation.
Related Docs
View other Related Docs
1. Obesity and Angiogenesis, Journal of Isfahan Medical School (2012)
2. Obesity and Inflammation: Role of Adipokines, Journal of Isfahan Medical School (2016)
3. The Exercise Training Modulatory Effects on the Obesity-Induced Immunometabolic Dysfunctions, Diabetes, Metabolic Syndrome and Obesity (2020)
Experts (# of related papers)
View all Related Experts
Bahman Rashidi (4)
Nizal Sarrafzadegan (2)
Other Related Docs
4. Ghrelin Does Not Modulate Angiogenesis in Matrigel Plug in Normal and Diet-Induced Obese Mice, Journal of Research in Medical Sciences (2013)
5. Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments, International Journal of Molecular Sciences (2020)
6. A Review on Angiogenesis and Its Assays, Iranian Journal of Basic Medical Sciences (2012)
7. Systemic Administration of Ghrelin Did Not Restore Angiogenesis in Hindlimb Ischemia in Control and Diet-Induced Obese Mice, Bratislava Medical Journal (2015)
8. Adiponectin: An Adipokine With Protective Features Against Metabolic Syndrome, Iranian Journal of Basic Medical Sciences (2015)
9. Systemic Ghrelin Administration Alters Serum Biomarkers of Angiogenesis in Diet-Induced Obese Mice, International Journal of Peptides (2013)
10. Pivotal Role of Microrna-33 in Metabolic Syndrome: A Systematic Review, ARYA Atherosclerosis (2013)
11. Angiopoietin-Like Proteins 2 and 3 in Children and Adolescents With Obesity and Their Relationship With Hypertension and Metabolic Syndrome, International Journal of Hypertension (2021)
12. Why Might South Asians Be so Susceptible to Central Obesity and Its Atherogenic Consequences? the Adipose Tissue Overflow Hypothesis, International Journal of Epidemiology (2007)
13. Comparative Effects of Carbohydrate Versus Fat Restriction on Serum Levels of Adipocytokines, Markers of Inflammation, and Endothelial Function Among Women With the Metabolic Syndrome: A Randomized Cross-Over Clinical Trial, Annals of Nutrition and Metabolism (2013)
14. Impact of Omega-3 Fatty Acids Supplementation on the Gene Expression of Peroxisome Proliferator Activated Receptors-Γ, Α and Fibroblast Growth Factor-21 Serum Levels in Patients With Various Presentation of Metabolic Conditions: A Grade Assessed Systematic Review and Dose–Response Meta-Analysis of Clinical Trials, Frontiers in Nutrition (2023)
15. Correlations Between Serum Leptin and Nitric Oxide Concentrations in Obese and Control Balb/C Mice, Journal of Isfahan Medical School (2013)
16. Inflammation-Induced Atherosclerosis As a Target for Prevention of Cardiovascular Diseases From Early Life, Open Cardiovascular Medicine Journal (2010)
17. Green Tea and Its Anti-Angiogenesis Effects, Biomedicine and Pharmacotherapy (2017)
18. Ghrelin Does Not Alter Aortic Intima-Media Thickness and Adipose Tissue Characteristics in Control and Obese Mice, Iranian Journal of Basic Medical Sciences (2013)
19. Imbalance of Angiogenesis in Diabetic Complications: The Mechanisms, International Journal of Preventive Medicine (2012)
20. An Overview of Fgf19 and Fgf21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity, Hormone and Metabolic Research (2018)